Score Overview
Explore the 2021 public Archive ranking โ
Where VivoSim Labs, Inc. has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. VIVS does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-11-17 | $ 0.12 | โ |
1 Year2025-11-17 | $ 2.28 | -94.73% |
5 Years2021-11-17 | $ 63.24 | -99.81% |
10 Years2016-11-17 | $ 763.20 | -99.98% |
All Time2012-02-14 | $ 396.00 | -99.97% |
| Period | Last Price2026-11-17 | 1 Year2025-11-17 | 5 Years2021-11-17 | 10 Years2016-11-17 | All Time2012-02-14 |
|---|---|---|---|---|---|
| Price | $ 0.12 | $ 2.28 | $ 63.24 | $ 763.20 | $ 396.00 |
| Return | โ | -94.73% | -99.81% | -99.98% | -99.97% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 135K | -$ 10M | $ 8M |
| 2026 | $ 131K | -$ 13M | $ 5M |
| 2025 | $ 144K | -$ 2M | $ 11M |
| 2024 | $ 109K | -$ 14M | $ 2M |
| 2023 | $ 370K | -$ 17M | $ 16M |
| 2022 | $ 1M | -$ 11M | $ 28M |
| 2021 | $ 0.00 | -$ 16M | $ 37M |
| 2020 | $ 2M | -$ 18M | $ 27M |
| 2019 | $ 3M | -$ 26M | $ 36M |
| 2018 | $ 4M | -$ 34M | $ 43M |
| 2017 | $ 4M | -$ 38M | $ 62M |
| 2016 | $ 1M | -$ 38M | $ 62M |
| 2015 | $ 571K | -$ 30M | $ 50M |
| 2014 | $ 379K | -$ 25M | $ 48M |
| 2013 | $ 1M | -$ 43M | $ 14M |

VivoSim Labs, Inc. fundamental performance
Between 2021 and 2026, revenue grew from $ 0.00 to $ 131K and net income went from -$ 16M to -$ 13M. Revenue increased in 2 of those 5 years; net income in 3.
Between 2016 and 2026, revenue declined from $ 1M to $ 131K and net income went from -$ 38M to -$ 13M. Revenue increased in 4 of those 10 years; net income in 8.
VivoSim Labs, Inc. currently holds a 5-year HDB Score of 4.4 out of 10. How the HDB Score is calculated.
Membership
Explore VIVS with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,187 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Atrium Therapeutics, Inc. Common StockRNAยท revenue grew in 80% of years
Mirum Pharmaceuticals IncMIRMยท revenue grew in 100% of years
Neuroone Medical Technologies CorpNMTCยท revenue grew in 60% of years
Purple BiotechPPBTยท revenue grew in 20% of years
ImmunoPrecise Antibodies Ltd.HYFTยท revenue grew in 80% of years